Marwan Bukhari
Marwan Bukhari
Consultant rheumatologist and honorary senior lecturer
Adresse e-mail validée de mbht.nhs.uk
Titre
Citée par
Citée par
Année
Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large …
M Bukhari, M Lunt, BJ Harrison, DGI Scott, DPM Symmons, AJ Silman
Arthritis & Rheumatism: Official Journal of the American College of …, 2002
2722002
Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study
MAS Bukhari, NJ Wiles, M Lunt, BJ Harrison, DGI Scott, DPM Symmons, ...
Arthritis & Rheumatism 48 (1), 46-53, 2003
2182003
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
T Ding, J Ledingham, R Luqmani, S Westlake, K Hyrich, M Lunt, P Kiely, ...
Rheumatology 49 (11), 2217-2219, 2010
2092010
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co‐expressed with VEGF in synovial fluid
MJ Bottomley, NJA Webb, CJ Watson, L Holt, M Bukhari, J Denton, ...
Clinical & Experimental Immunology 119 (1), 182-188, 2000
1592000
Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
LK Mercer, M Lunt, ALS Low, WG Dixon, KD Watson, DPM Symmons, ...
Annals of the rheumatic diseases 74 (6), 1087-1093, 2015
1342015
Time to first occurrence of erosions in inflammatory polyarthritis: Results from a prospective community‐based study
M Bukhari, B Harrison, M Lunt, DGI Scott, DPM Symmons, AJ Silman
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
1312001
Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy
M Bukhari, S Hollis, T Moore, MIV Jayson, AL Herrick
Rheumatology 39 (5), 506-512, 2000
1262000
The performance of anti–cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk …
M Bukhari, W Thomson, H Naseem, D Bunn, A Silman, D Symmons, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
1252007
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
SB Cohen, E Keystone, MC Genovese, P Emery, C Peterfy, PP Tak, ...
Annals of the rheumatic diseases 69 (6), 1158-1161, 2010
119*2010
Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease …
NJ Wiles, M Lunt, EM Barrett, M Bukhari, AJ Silman, DPM Symmons, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
1182001
Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease …
NJ Wiles, M Lunt, EM Barrett, M Bukhari, AJ Silman, DPM Symmons, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
1182001
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis
ASL Low, DPM Symmons, M Lunt, LK Mercer, CP Gale, KD Watson, ...
Annals of the rheumatic diseases 76 (4), 654-660, 2017
782017
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy
C Deighton, K Hyrich, T Ding, J Ledingham, M Lunt, R Luqmani, P Kiely, ...
Rheumatology 49 (6), 1197-1199, 2010
752010
Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis
M Bukhari, AL Herrick, T Moore, J Manning, MIV Jayson
Rheumatology 35 (11), 1127-1131, 1995
751995
Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis
M Jani, H Chinoy, RB Warren, CEM Griffiths, D Plant, B Fu, AW Morgan, ...
Arthritis & Rheumatology 67 (8), 2011-2019, 2015
712015
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
LK Mercer, JB Galloway, M Lunt, R Davies, ALS Low, WG Dixon, ...
Annals of the rheumatic diseases 76 (3), 497-503, 2017
682017
Alkaptonuria
JB Mistry, M Bukhari, AM Taylor
Rare Diseases 1 (1), e27475, 2013
672013
Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis
A Barton, H Platt, F Salway, D Symmons, E Barrett, M Bukhari, M Lunt, ...
Annals of the rheumatic diseases 63 (3), 280-284, 2004
572004
Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis
M Bukhari, M Lunt, A Barton, D Bunn, A Silman, D Symmons
Annals of the rheumatic diseases 66 (3), 389-393, 2007
562007
HFE mutations in an inflammatory arthritis population
G Willis, DGI Scott, BA Jennings, K Smith, M Bukhari, JZ Wimperis
Rheumatology 41 (2), 176-179, 2002
512002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20